Meeting
2018 ASCO Annual Meeting
Adjuvant chemotherapy and survival outcomes in diabetic patients with colon cancer: A population-based analysis.
Authors
Shiru Lucy Liu
BC Cancer Agency, Vancouver, BC, Canada
Shiru Lucy Liu , Sharlene Gill , Winson Y. Cheung
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 36, 2018 (suppl; abstr 3589)
DOI
10.1200/JCO.2018.36.15_suppl.3589
Abstract #
3589
Poster Bd #
82
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Early survival outcomes in stage I-III operated colon cancer patients from a low prevalence, lower-middle income country: The Indian experience.
First Author: Rushabh Kiran Kothari
Poster
2023 ASCO Quality Care Symposium
Impact of the IDEA collaboration study on practice patterns of adjuvant chemotherapy in patients with stage III colon cancer: A population-based study.
First Author: Sunil Samnani
Poster
2021 ASCO Annual Meeting
Real-world survival outcomes associated with completion of adjuvant chemotherapy for stage III colon cancer.
First Author: Jemma Megan Boyle
Poster
2021 Gastrointestinal Cancers Symposium
Final results of the ACTS-CC 02 trial: A randomized phase III trial of S-1/oxaliplatin (SOX) versus UFT/leucovorin as adjuvant chemotherapy for high-risk stage III colon cancer.
First Author: Naohiro Tomita